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Abstract
African swine fever is a devastating disease of domestic swine and wild boar caused by a large double- stranded DNA virus 
that encodes for more than 150 open reading frames. There is no licensed vaccine for the disease and the most promising 
current candidates are modified live viruses that have been attenuated by deletion of virulence factors. Like many viruses 
African swine fever virus significantly alters the host cell machinery to benefit its replication and viral genes that modify 
host pathways represent promising targets for development of gene deleted vaccines. Autophagy is an important cellular 
pathway that is involved in cellular homeostasis, innate and adaptive immunity and therefore is manipulated by a number 
of different viruses. Autophagy is regulated by a complex protein cascade and here we show that African swine fever virus 
can block formation of autophagosomes, a critical functional step of the autophagy pathway through at least two different 
mechanisms. Interestingly this does not require the A179L gene that has been shown to interact with Beclin-1, an important 
autophagy regulator.
InTRoduCTIon
African swine fever virus (ASFV) causes an invariably fatal 
haemorrhagic disease of domestic pigs and wild boar that 
is now widely distributed across four of the world’s conti-
nents. Efforts to control the disease have been frustrated 
in part by the lack of an effective vaccine. Live attenuated 
viruses represent the mostly promising route to a commer-
cial vaccine in the short term and modified live viruses 
produced by targeted gene deletion have a superior safety 
profile when compared to attenuated viruses generated by 
passage through tissue culture. Identifying genes capable of 
manipulating host cell responses has proven a fruitful way 
of identifying potential virulence factors [1–3] and gene 
deleted viruses based on these results have showed signifi-
cant promise as vaccine candidates [4–9]. Recombinant 
virus lacking genes encoding for proteins that modulate 
lymphocyte proliferation [8, 10], block stress responses 
[11] or support virus replication [12] have proven effective 
at protecting animals from virulent challenge, however 
these strategies do not always translate to different ASFV 
genotypes [9, 10, 13, 14]. Gene deletions focused on a 
locus that modulates the host interferon response [1, 15] 
and encodes multiple multigene family 360 (MGF360) and 
MGF505 genes attenuates three different ASFV genotypes 
[4, 6, 9, 16].
Autophagy is a constitutive cellular process of bulk degra-
dation that leads to elimination and recycling of cytosolic 
cell constituents by delivery to mammalian lysosomes 
or plant and yeast vacuoles [17]. To date, three distinct 
types of autophagy have been described, microautophagy, 
chaperone- mediated autophagy, and macroautophagy and 
in this text when we refer to ‘autophagy’ we refer to the 
process of macroautophagy which is centred on the incor-
poration of cargo into specialised vesicular organelles called 
autophagosomes. These migrate to and fuse with lysosomes 
which then breakdown cargo, which can include damaged 
organelles, long- lived proteins, and even invasive patho-
gens. Autophagy is regulated by a complex protein cascade 
that includes the mammalian target of rapamycin (mTOR) 
complex (mTORC), which acts on the ULK complex 
[18, 19], which in turns acts on the vacuolar protein sorting 
34 (Vps34) lipid kinase complex [20] that includes a Bcl-2 
like protein called Beclin-1 [21]. Two downstream ubiquitin 
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Atg12 to Atg5 to form the Atg16 complex, which then drives 
the lipidation of the Atg8 family of proteins, including 
LC3, which are major structural proteins of the nascent 
autophagosome. mTOR itself is regulated by the PI3K/Akt 
signalling cascade [22] and elevated levels of phosphoryl-
ated 4E- BP1 have been detected in Vero cells infected with 
a tissue cultured adapted strain of ASFV [23] suggesting 
that ASFV may also activate mTOR.
Autophagy acts as an intrinsic defence mechanism by 
degrading cytosolic or vacuole- containing microbes [24]. 
TLR4 activation can lead to release of Beclin-1 from Bcl-2 
via binding to TLR adaptor proteins which initiate an 
autophagy response [25]. Additionally, evidence suggests 
that considerable cross- talk exists between autophagy and 
the interferon response [26]. For example, expression of 
RNA- dependent eIF2α protein kinase (PKR), an important 
interferon- stimulated gene (ISG) product is essential for 
autophagic degradation of HSV-1 [27]. Collectively, studies 
such as these demonstrate an integral role of autophagy in 
innate immunity. Cytosolic proteins have been shown to 
be constitutively delivered to multi- vesicular MHC class 
II- loading compartments via fusion with autophagosomes. 
In this way, targeting of the influenza matrix protein 1 to 
autophagosomes led to strongly enhanced MHC class II 
presentation to CD4+ T cell clones [28]. Autophagy can 
also influence MHC class I presentation and enhance the 
presentation of viral antigens during HSV-1 infection [29].
With such an important role in the host response to 
infection, it is unsurprising that autophagy is modulated 
by viruses. Herpesviruses are targeted for degradation 
by autophagy (a process referred to as xenophagy) and 
the HSV-1 Us11 protein has been shown to inhibit PKR- 
mediated induction of autophagy [30]. The ICP34.5 protein 
of HSV-1 contains a Beclin-1 interacting domain that binds 
and inhibits the Beclin-1’s ability to activate autophagy 
[31]. Beclin-1 is a common target for virus modulation 
and the ASFV A179L gene encodes for a Beclin-1 binding 
protein that has a high degree of sequence homology to 
the proto- oncogene Bcl-2 [32–34]. Beclin-1 denotes an 
important point of convergence between the apoptosis 
and autophagy pathways perhaps making it a particularly 
useful target for inhibition by viruses [35]. ASFV seems to 
exploit this cross- over as exogenous expression of A179L 
leads to the inhibition of both apoptosis and the formation 
of autophagosomes [33, 36, 37].
Modifying the ability of viruses to control the autophagy 
response can significantly alter the outcome of infection. 
Infection of mice with the recombinant HSV-1 mutant virus 
lacking the Beclin-1 binding domain of ICP34.5 resulted 
in reduced mortality compared to wild- type virus [31], 
demonstrating the potential for exploiting autophagy as 
a means of viral attenuation. A separate study using this 
virus showed that infection resulted in a significantly 
stronger CD4+ T cell response to recall antigen [38] and 
the cellular immune response plays an important role in 
protection against ASFV [39, 40]. Therefore, we reasoned 
that modulation of autophagy may play an important part 
in ASFV replication biology and could provide a target 
for rational design of vaccines. For example, the immu-
nogenicity of vaccine strain viruses could be enhanced 
by limiting the ability of the virus to modulate autophagy 
which may lead to increased antigen presentation and a 
greater T- cell response.
METHodS
Cells and viruses
Vero African green monkey kidney cells were cultured in 
DMEM supplemented with 10 % FCS, 25 mM HEPES and 
100 U ml−1 streptomycin and 100 U ml−1 penicillin. The Vero 
adapted Badajoz 1971 strain (Ba71v) and Ba71vΔA179L 
have been described previously and were grown on Vero 
cells [41, 42]. The titre determined by endpoint dilution 
on Vero cells using expression of p30 as a marker for 
infection. Virus titrations were stained as for confocal 
microscopy below using anti- p30 clone C18, read using 
an inverted microscope and the TICD50 determined using 
the Spearman- Kärber method [43]. For infections, Vero 
cells were seeded at 2.5×104 cells cm−2 and the following 
day virus was diluted in DMEM supplemented with 2 % 
FCS and incubated on cells for 1 h at 37 °C. The inoculum 
was removed, the cells washed and replaced with fresh 
2 %-DMEM – this constituted the 0 h post- infection (hpi) 
time point.
SdS-PAGE and immunoblotting
Proteins from cell lysates were resolved by SDS- PAGE 
(sodium dodecyl sulphate polyacrylamide gel electropho-
resis) in NuPAGE MES running buffer (ThermoFisher 
Scientific) with the exception of gels for LC3 analysis that 
were run in NuPAGE MOPS running buffer (ThermoFisher 
Scientific). Proteins were transferred onto PVDF membranes 
for 1 h in transfer buffer (25 mM Trizma, 190 mM glycine, 
20 % methanol), blocked in buffer consisting of TBS with 
0.2 % (v/v) Tween (TBS- T) and 5 % (w/v) milk powder for 
1 h, prior to overnight incubation with primary antibody 
diluted in blocking buffer. A list of antibodies used for both 
immunoblotting and confocal microscopy are provided in 
the supplemental data that accompanies this manuscript. 
Membranes were washed three times in TBS- T, prior to 
incubation with appropriate HRP- conjugated secondary 
antibodies, which had been diluted in blocking buffer, for 
1 h. Membranes were washed a further three times in TBS- T 
prior to detection of chemiluminescence by incubating the 
membrane with Pierce ECL Western blotting substrate 
(ThermoFisher Scientific) for 3 min. Membranes were 
then imaged using a G:Box Chemi system (Syngene). The 
Gel Analysis function of ImageJ was used to calculate the 
relative density of loading controls and proteins of interest 
and the relative normalised density of proteins of interest 
derived by dividing the relative density of the protein of 
interest by that of the loading control.
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Confocal microscopy
Cells were fixed in 4 % PFA for 30 min followed by permea-
bilisation using methanol and then washed three times with 
PBS before incubating for 1 h in block buffer consisting 
of 10 % (v/v) TBS, 0.2 % (v/v) NaN3 and 0.2 % (v/v) fish 
skin gelatin (Sigma). Coverslips were then incubated 
for a further hour in primary antibody diluted in block 
buffer and then washed three times for 5 min in PBS to 
remove excess antibody. Next, coverslips were incubated 
for 1 h with an appropriate secondary antibody diluted 
in block buffer and then washed three times in PBS (-) 
before incubation with 1 µg ml−1 DAPI nuclear stain (4′, 
6- diamidino-2- phenylindole, dihydrochloride, Sigma) in 
H2O for 10 min. Finally, coverslips were washed twice in 
ddH2O and then mounted in Vectashield (Vector Laborato-
ries) on glass slides, and sealed using nail varnish. Cells were 
visualised using a Leica confocal laser scanning microscope, 
and data analysed using LAS X (Leica Confocal Software) 
and the ‘Cells’ analysis package of Imaris (Oxford Instru-
ments Group, version 9.2.1) using the ‘Cells’ analysis func-
tion. Cells were detected using cytoplasmic LC3 staining or 
p30 labelling of protein expression following infection or 
transduction. Detection thresholds were adjusted to cover 
each cell to the cell boundary. The software was set to detect 
puncta of approximately 0.5 µm in diameter and cells were 
visually inspected to ensure that the software had accurately 
identified visible puncta. Analysis was carried out for at 
least 30 cells per experimental condition.
Statistics
Statistical analysis of data was performed with Graphpad 
(Prism, version 8.2).
RESuLTS
The effects of ASFV on autophagy 4 h post- infection (hpi) 
are shown in Fig. 1. Induction of autophagy was assessed 
by counting autophagosomes in cells starved in EBSS in the 
presence or absence of virus. Fig. 1(a, b) show that starvation 
induced autophagosomes labelled with LC3 in uninfected 
cells and mock infected cells, but numbers of LC3 puncta 
were reduced in cells infected with ASFV (Fig. 1c) This was 
quantified by counting puncta in cells counterstained for 
viral protein p30 (Fig. 1d, e). Starvation of control or mock 
infected cells in EBSS generated between 10 and 15 puncta per 
cell, but it was not possible to detect LC3 puncta in infected 
cells identified by immunostaining for p30. Autophagy can 
also be assessed by following the conversion of LCI to LC3II 
during the conjugation of LC3 to phosphatidylethanolamine 
(PE) in the autophagosome membrane. Western blot (Fig. 1f) 
shows that the levels of the faster migrating LC3II increased 
after starvation but LC3II levels were reduced in infected 
cells. Taken together with the confocal microscopy data this 
suggested that ASFV blocked starvation- induced formation 
of autophagosomes in Vero cells. Significant changes in 
autophagosome numbers over the course of sixteen hours 
were not observed (Fig. S1), consistent with analysis of levels 
of LC3II by immunoblotting [33]. Furthermore, ASFV was 
able to block the formation of starvation induced autophago-
somes at all of the time points tested (Fig. S1). The ability 
of virulent field isolates to inhibit autophagy in porcine 
macrophages, which are the natural host cell of ASFV, was 
also tested. The high auto- fluorescence of macrophages made 
it difficult to identify LC3 puncta by microscopy. Autophago-
some formation was therefore monitored by immunoblotting 
for LC3. Similar to what was observed in Vero cells, induction 
of autophagy in macrophages infected with the virulent OUR 
T88/1 ASFV isolate by Torin2 did not increase levels of LC3- II 
(Fig. S2) suggesting that field isolates of ASFV could inhibit 
autophagosome formation in primary macrophages.
The autophagy cargo protein, SQSTM1/p62 is degraded after 
the fusion of autophagosomes with lysosomes. This allows a 
fall in levels of p62 to serve as a useful index of autophagic 
degradation. Western blots (Fig. 2a, b) show that starvation 
of Vero cells for 1 h reduced steady state levels of p62 by 
approximately one half, and this was blocked by addition 
of the vacuolar H+ATPase inhibitor bafilomycin A1, that 
prevents fusion between autophagosomes and lysosomes [44]. 
This drop in p62 was seen in cells mock infected for 4 or 12 h 
prior to starvation, but the loss of p62 was not seen in when 
cells infected with ASFV were starved in EBSS (Fig. 2d, e)
Beclin-1 is part of the Vps34 lipid kinase complex upstream of 
the Atg5- Atg12 and Atg8/LC3 conjugation systems. Beclin-1 
is held in an inactive complex with Bcl2 and dissociation of 
Beclin 1 from Bcl2 is required for autophagy induction [45]. 
The Bcl-2 homologue A179L encoded by ASFV interacts 
with Beclin-1 [33, 37, 46] and can prevent starvation induced 
formation of autophagosomes in transduced cells [37]. The 
possibility that A179L provided the inhibition of autophagy 
observed in Figs 1 and 2 was tested by assessing autophagy 
in starved cells infected with a viral strain carrying a dele-
tion in A179L (Ba71vΔA179L). Figs S1 and S3 shows that 
autophagosome formation was inhibited following infection 
with Ba71vΔA179L suggesting that A179L is not necessary for 
viral inhibition of autophagy. A179L binds to peptides span-
ning the BH3 motifs of cellular Bcl2 proteins such as Bid, Bim, 
and Puma with between 50 to 300 times greater affinity than 
to peptides derived from Beclin-1 [46], therefore A179L may 
preferentially interact with other Bcl2 proteins in infected 
cells rather than Beclin-1. The apparent absence of a func-
tional role for A179L in ASFV inhibition of autophagosome 
formation and the lack of other candidate ASFV encoded 
Bcl-2 homologues led us to investigate whether inhibition 
of autophagy by ASFV occurred earlier in the autophagy 
signalling cascade.
mTORC1 is activated in nutrient rich conditions and inhibits 
autophagy [47] by phosphorylating ULK1 to supresses the 
kinase activity of the ULK1 complex. At the same time 
mTORC1 phosphorylates p70- S6K and 4E- BP1 to increase 
translation of mRNA. The effect of ASFV on phosphoryla-
tion of ULK1 (P- ULK1), p70- S6K (P- p70- S6K) and 4E- BP1 
(P- 4E- BP1) in cells incubated in nutrient media or starved 
in EBSS is shown in Fig.  3(a). As expected, starvation of 
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uninfected cells decreased phosphorylation of ULK1, p70 
S6K and 4E- BP1 indicating inhibition of mTORC1. Levels 
of p- ULK1 remained constant during the first 4 hpi of infec-
tion and then rose slightly compared to mock infected cells 
up to 16 hpi suggesting up regulation of mTORC1 by ASFV. 
Interestingly, P- p70- S6K was elevated after 1 h preincubation 
with virus (0 hpi). Levels of P- p70- S6K then fell transiently 
at 1 hpi, but increased dramatically between 4 to 16 hpi. A 
similar, but less pronounced effect was seen with P- 4E- BP1. 
Analysis of total protein levels of ULK1, p70- S6K and 4E- BP1 
as well as γ-tubulin showed this was not due to changes in 
the steady state levels of the individual proteins. A similar 
pattern of phosphorylation of mTORC1 substrates was seen 
in macrophages infected with a virulent field strain (Fig. S4). 
The results suggested that ASFV inhibited autophagy by acti-
vating mTORC1 in cells in nutrient media. The activation of 
mTORC1 by ASFV was tested further by analysing p70- S6K 
in starved cells (Fig. 3b). P- p70- S6K was absent from mock 
infected cells, however levels of P- p70- S6K increased during 
ASFV infection peaking between 4 hpi and 8 hpi, before 
decreasing again at 16 hpi. This data suggested that activa-
tion of mTORC1 allows ASFV to circumvent activation of 
autophagy during starvation.
The activity of mTORC1 is increased by Akt either directly via 
Akt- mediated phosphorylation and suppression of TSC2, or 
Fig. 1. ASFV blocks starvation induced formation of autophagosomes. Vero cells were incubated with media alone (a, e), mock inoculum 
(b, f) or Ba71V (c, d, g, h) for 1 h. Inocula were removed and cells were incubated for a total of 4 h during which cells were either incubated 
in media (a–d) starved in EBSS for the final 2 h (e–h). Cells were then processed for, and analysed by, confocal microscopy (Panels a–i) 
or immunoblotting (Panel j). (a–h) Confocal images of cells labelled for LC3 (green), nuclei (blue) and p30 (red). Panels c and g shows 
the same infected cells as Panel d and h respectively, but with the red channel removed to allow for clearer observation of LC3 staining. 
Scale bars represent 10 µm. (i) The number of LC3 puncta per cell for 30 individual cells per indicated experimental condition was 
quantified by Imaris analysis of confocal images (NS - complete cell media, ST - starved in EBSS). Centre lines show the medians and 
differences between the indicated medians were tested using a Kruskal- Wallis test. Asterisks represent significant differences in value 
between NS and ST conditions ****=P value of <0.0001). (j) Immunoblots were probed with anti- LC3, anti- p30 and γ-tubulin antibodies. 
The positions of molecular mass markers are indicated to the left of the gels.
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via inhibition of AMPK [48]. Activation of Akt during ASFV 
infection was assessed by Western blot of phosphorylated 
T308 and S473 residues on Akt [49] (Fig. 4a). Starvation, or 
inhibition of Akt signalling by the PI3K inhibitor LY294002, 
led to a reduction in P- Akt T308, and a near absence of P- Akt 
S473. ASFV had little effect on phosphorylation of Akt T308, 
even so ASFV appeared to activate Akt early during infec-
tion indicated by raised levels of p- Akt S473 at 2 hpi, which 
reached a maximum at 4 and 8 hpi and S473 Akt remained 
phosphorylated throughout the ASFV replication cycle. This 
suggested that activation Akt may drive activation of mTORC1 
and inhibition of autophagy by ASFV. It was also possible that 
mTORC1 may have been activated independently of Akt via 
AMPK, which activates the TSC complex.
The possibility that mTORC1 was activated by Akt during 
ASFV infection was tested using MK-2206 to inhibit Akt 
[50, 51]. Fig. 4(b) shows cells analysed 4 h post- infection, 
when phosphorylation of Akt appeared to be greatest, and 
viral protein p30 could be clearly detected. In conventional 
media, raised levels of P- Akt S473 and P- Akt T308 were 
evident in ASFV infected cells compared to mock infected 
cells indicating viral activation of Akt. At the same time 
downstream activation of mTORC1 was indicated by phos-
phorylation of p70 S6K. MK-2206 blocked phosphorylation 
of Akt T308 in mock and virally infected cells. MK-2206 also 
blocked P- Akt S473 in mock infected cells but it was still 
possible to detect low levels of P- Akt S473 in ASFV infected 
cells. This suggested that MK-2206 alone can inactivate Akt 
in mock infected cells, but can only partially inactivate Akt 
in ASFV infected cells.
While the mTORC1 complex acts as a nutrient sensor upstream 
of autophagy, the catalytic subunit of mTORC1 (mTOR) can 
be incorporated into a second complex called mTORC2 that 
phosphorylates S473 residue of Akt independently of nutrient 
signalling. The preferential phosphorylation of S473 seen in 
infected cells suggested that ASFV may activate mTORC2. 
The experiments were therefore repeated for cells incubated 
with Torin1, which inhibits both mTORC1 and mTORC2. 
Torin1 resulted in a loss of P- p70- S6K and P- Akt S473 respec-
tively (Fig. 4b). This shows that Torin1 inactivated mTORC1 
Fig. 2. ASFV inhibits starvation- induced degradation of p62. (a) Vero cells were either incubated in complete cell media (NS), starved in 
EBSS (ST) or starved in EBSS in the presence of 100 nM bafilomycin A1 (BAF) for 1 h. Cells lysates were processed for immunoblot and 
probed with anti- p62 and γ-tubulin. (b) The relative densities of the p62 bands were calculated by comparison to that of the non- starved 
sample before being normalised to the values of γ-tubulin. (c, d) Vero cells were incubated with mock inoculum (Panel a) or Ba71V (MOI 
5) (Panel b) for 1 h and then incubated for a total of 4 h or 12 h during which cells were either incubated in complete cell media (NS) or 
starved in EBSS (ST) for the final 2 h. Cells were lysed and immunoblots probed with anti- p62, anti- p30 and γ-tubulin antibodies. (e) 
Relative densities of the p62 bands were calculated by comparison to those of the 4 hpi non- starved sample before normalising the 
values to those of γ-tubulin. This was carried out separately on the mock infected and ASFV infected samples. Finally, the ratio of starved 
(ST) to non- starved (NS) values were calculated for mock infected and ASFV infected samples at 4 hpi and 12 hpi. (a, c, d) The positions 
of molecular mass markers are indicated to the left of the gels. Densitometry data represents the mean of three experiments and error 
bars indicate SD. Statistical analysis was carried out using one- way analysis of variance with Tukey multiple comparisons test. Asterisks 
represent a significant difference in value between the indicated conditions (*=P value of <0.05, **=P value of <0.01, ***=P value of <0.001).
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and prevented downstream phosphorylation of p70- S6K, 
and also inhibited mTORC2- mediated phosphorylation of 
Akt on S473. Importantly, phosphorylation of Akt T308 was 
still apparent indicating activation of Akt by ASFV. This was 
confirmed when P- Akt T308 was lost when Akt was inhibited 
by MK-2206 in the presence of Torin1, or following starva-
tion in EBSS. Collectively these results suggest that ASFV 
inhibits autophagy by two pathways involving Akt. Direct 
activation of Akt leads to phosphorylation of S473 and T308 
and activation of mTORC1, and this is inhibited by MK-2206. 
A second pathway activates Akt indirectly through activation 
of mTORC2 and phosphorylation of S473.
The effects of Torin1 and MK-2206 on generation of LC3 
puncta during ASFV infection are shown in Fig. 5. Cells were 
preincubated with ASFV for an hour and then incubated in 
EBSS for 2 h to activate autophagy. Mock infected cells gener-
ated large numbers of LC3 puncta (Fig. 5a, b), which were 
not detected in ASFV infected cells (Fig. 5e, f). Substantial 
numbers of autophagosomes were however observed when 
infected cells were incubated in EBSS, Torin1 and MK-2206 
(Fig. 5h, i). To investigate if this effect was linked to the early 
stages of infection the analysis was repeated 4 hpi. In contrast 
to 2 hpi, it was difficult to detect LC3 puncta in infected cells 
positive for p30 staining (Fig. 5b, c). The lower numbers of 
autophagosomes present in cells treated with Torin1 and 
MK-2206 at 4 hpi when compared to 2 hpi suggests that viral 
proteins expressed 4 hpi may still be able to supress induc-
tion of autophagosomes. Similar results were observed in cells 
infected with Ba71vΔA179L (Fig. S5) suggesting even if Akt 
and mTORC are inactivated A179L does not contribute to the 
block in autophagosome formation.
dISCuSSIon
To initiate and sustain a productive infection, viruses require 
a tremendous amount of cellular resources which inevitably 
activates stress response pathways such as the unfolded 
protein response (UPR) and apoptosis. Viruses are thus 
Fig. 3. ASFV activates mTORC1 early during infection. (a) Vero cells were either mock infected or infected with Ba71V (MOI 5) for 1 h 
before residual virus was washed off and the 0 h time point was harvested. The remaining cells were incubated in 2 % media and 
harvested at multiple time points over a 16 h time course of infection. Control cells were either incubated in complete cell media (NS) 
or starved (ST) in EBSS for 3 h to induce inactivation of mTORC1. (b) Vero cells were infected with Ba71V (MOI 5) and harvested at 
multiple time points over a 16 h time course of infection. Prior to harvest, cells were starved for 1 h in EBSS. Separately, cells were mock 
infected for a total of 16 h and either incubated in complete cell media or starved for 1 h in EBSS prior to harvest. (a, b) Cells were lysed, 
processed for immunoblot and probed with the indicated antibodies. The time post- infection in hours (hpi) are indicated at the top of the 
gel, the positions of molecular mass markers are indicated to the left.
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required to overcome or limit the effects of these pathways 
and research has showed that ASFV encodes multiple modu-
lators for this purpose [52]. Autophagy is a highly conserved 
process that is not only vital to the host cell stress response 
but also plays an integral role in both innate and adaptive 
immunity. Presenting such a potent threat, autophagy is 
specifically targeted for inhibition by numerous viruses and 
even harnessed by some to act in a pro- viral manner [53–56]. 
ASFV encodes a protein, A179L that was shown to specifically 
bind to the key autophagy protein Beclin-1 which forms part 
of the Vps34 lipid kinase complex [33]. The Vps34 complex 
is essential during the very early stages of the autophagy 
pathway and over- expression of A179L inhibits the forma-
tion of starvation- induced autophagosomes [37]. Research 
has showed however that viruses often modulate autophagy 
at multiple steps in the pathway. For example, HSV-1 inhibits 
Beclin-1 function but can also inhibit stimulatory signals that 
are situated higher up in the pathway [30, 31].
LC3- labelling for autophagosomes in Veros cells infected 
with the tissue culture adapted strain Ba71V showed that 
ASFV infected cells had reduced numbers of autophago-
somes at 4 hpi when compared to control cells under 
nutrient replete conditions. This suggested that ASFV does 
not promote autophagy during the early stages of viral repli-
cation and is consistent with previous results shown at later 
time points during the virus replication cycle [33]. Cells were 
then starved to test if autophagy is inhibited by ASFV and in 
comparison to the high number of autophagosomes detected 
in control cells, a significantly lower number were detected 
Fig. 4. ASFV targets AKT. (a) Vero cells were either mock infected or infected with Ba71V (MOI 5) for 1 h before residual virus was washed 
off and the 0 h time point was harvested. The remaining infected cells were incubated in 2 % media and harvested at multiple time points 
over a 16 h time course of infection. Control cells were either non- starved (NS) in complete cell media, starved (ST) in EBSS, incubated 
in media containing DMSO or incubated in media containing 50 nM LY294002 for 3 h. (b) Vero cells were incubated with mock inoculum 
(mock infected) or Ba71V (MOI 5) for 1 h. Inocula were removed and cells were incubated for a total of 4 h. During the last 2 h, cells were 
incubated in regular 2 % media or in 2 % media containing 200 nM Torin1 or 5 µM MK-2206 or a combination of both drugs. Separately, 
cells were starved in EBSS in the presence of both drugs. (a, b) Cells were then lysed, processed for immunoblot and probed with 
antibodies against the indicated proteins. The positions of molecular mass markers are indicated to the left of the gels.
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in cells infected with ASFV, suggesting that the virus actively 
inhibits autophagy. Western blot analysis of LC3- II levels 
showed that ASFV was able to block starvation- induced 
accumulation of LC3- II in both cultured cells and primary 
macrophages at early times post- infection. Confocal experi-
ments showed that ASFV could inhibit autophagy during 
later time points in Vero cells, however this would need to 
be confirmed in macrophages. Consistent with inhibition 
of autophagosome formation p62 levels in starved ASFV 
infected Vero cells were not significantly degraded during 
the early or late stages of infection suggesting that the 
breakdown of cargo via autophagosome- lysosome fusion, 
known as autophagic flux, is inhibited by ASFV. Inhibition 
of LC3 lipidation in ASFV infected cells is different to that 
observed after infection by with vaccinia virus where aber-
rant lipidation of LC3 is promoted by direct conjugation 
between ATG12 and ATG3 [57].
ASFV encodes for a Bcl2 homologue that has been shown 
to interact with Beclin-1 in yeast two hybrid screens and is 
capable of blocking autophagosome formation when over-
expressed exogenously [33, 37]. However, an A179L ASFV 
deletion mutant virus was unable to prevent formation of 
autophagosomes suggesting that if A179L does play a role 
Fig. 5. Biomodal inhibition of autophagosome formation by ASFV. Vero cells were incubated with mock inoculum (Panel a, d, g) or Ba71V 
(MOI 5) (Panels b, c, e, f, h, i) for 1 h. Inocula were removed and cells were incubated for a total of either 2 h (a–f) or 4 h (g–i) either in the 
presence (d–i) or absence (a–c) of 200 nM Torin1 and 5 µM MK-2206 (T1/MK). Cells were also starved by incubating with EBSS for the 
final 2 h of the incubation, i.e. throughout the 2 h incubation. Cells were then fixed and labelled with antibodies against LC3 (green), p30 
(red) or with DAPI (blue). Panels c, f show the same infected cells as Panels B and E respectively but with the red channel removed to 
allow for clearer observation of LC3 staining. Scale bars represent 10 µm.
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in inhibiting autophagy in infected cells, it is not the only 
means of inhibition employed by the virus. Activation of 
mTORC1 is often required by viruses to maintain protein 
translation and its activation also inhibits autophagy via the 
ULK1 complex. In ASFV infected Vero cells, mTORC1 was 
active during both early and late stages of the replication cycle 
and furthermore the virus was capable of blocking inactiva-
tion of mTORC1 by starvation, suggesting that mTORC1 is 
specifically targeted by the virus. Activation of mTORC1 was 
observed in a time- dependent manner, becoming increas-
ingly apparent as infection progressed which may suggest that 
the expression of virally encoded proteins are required for 
this effect. This has been reported for HSV-1, where expres-
sion of the US3 kinase protein is directly linked to mTORC1 
activation [58]. Irrespective of the underlying mechanism, the 
ability of ASFV to activate mTORC1 represents a clear means 
by which autophagy may be inhibited. The ability of ASFV 
to maintain mTORC1 activity under conditions of cellular 
stress is shared with human cytomegalovirus, highlighting 
the importance of this pathway for successful propagation of 
large double stranded DNA viruses [59, 60].
mTORC1 activation is in turn regulated by activated Akt 
which can be measured by analysing phosphorylation at 
residues S473 and T308 [49]. Akt was active throughout the 
replication cycle and greater levels of phosphorylation at S473 
were observed in ASFV infected cells when compared to mock 
infected cells between 2 and 8 hpi. This suggests that mTORC 
and autophagy induction may be regulated at the point of Akt 
activation during viral infection. Phosphorylation of Akt at 
S473 is carried out by mTORC2 [61] which could suggest that 
mTORC2 activity may be stimulated by ASFV. The capacity of 
ASFV to inhibit autophagy induction in the absence of Akt/
mTORC1 activity was investigated using pharmacological 
inhibitors. Both MK-2206 and Torin1 were required to block 
phosphorylation of Akt at both S473 and T308 in ASFV 
infected cells. The observation that Torin1, an mTORC2 
inhibitor, was required to completely inactivate Akt in ASFV 
infected cells is consistent with the idea that mTORC2 may 
be targeted by ASFV to drive Akt activation. Techniques for 
the specific inhibition of mTORC2 are beginning to emerge 
[62] which could be useful in determining if mTORC2 plays 
a role in ASFV infection. Future studies could also test if Akt 
is exclusively responsible for the activation of mTORC1 or if 
ASFV may be activating mTORC1 via alternative means such 
as virally encoded proteins. The PI3K/Akt signalling cascade 
is commonly targeted by viruses that rely on cap- dependent 
translation such as mammalian DNA viruses as they require 
active mTORC1 to maintain protein translation [63, 64]. The 
activation of the PI3K/Akt pathway by vaccinia virus (VACV) 
was shown to be required for viral growth although this was 
also linked to the inhibition of apoptosis [65]. Similarly, flavi-
viruses such as dengue virus and Japanese encephalitis virus 
activate the PI3K/Akt pathway which has an anti- apoptotic 
affect, as a block in this activation induced apoptotic cell death 
in the early stages of infection [66]. Human papillomavirus 
has been shown to activate the PI3K/Akt pathway, leading to 
the activation of mTORC1 and the inhibition of autophagy 
which benefits viral replication [67].
Inhibition of autophagosome formation at 2 hpi was concomi-
tant with activated mTORC1 and Akt, but low levels of viral 
gene expression, furthermore inhibition of autophagosomes 
at this time point could be prevented by pharmacological 
inhibition of Akt and mTORC1. This implies that activa-
tion of Akt was dependent on factors other than viral gene 
expression and it is possible that virus entry itself can induce 
activation of Akt as seen during VACV infection [65, 68]. As 
well as inhibiting autophagy via mTORC1, activated Akt can 
act directly on Beclin-1 [69] which could also contribute to 
early inhibition of autophagy after ASFV infection. By 4 hpi, 
early viral protein expression is well established and ASFV is 
able to substantially reduce the number of starvation- induced 
autophagosomes even in the presence of MK-2206 and Torin1. 
This was observed in cells infected with both wild- type virus 
and cells infected with Ba71vΔA179L suggesting that either 
A179L does not play a role in the inhibition of autophagy 
or that additional viral proteins are involved. ASFV particles 
contain 68 more viral proteins [70] that could play a role in 
manipulating host responses during or shortly after entry. The 
Fig. 6. Model of ASFV autophagy modulation. ASFV activates Akt and 
mTORC2. Activated Akt in turn activates mTORC1 which switches off 
autophagy via its action on ULK1. Blocking Akt and mTORC2 activity 
rescues autophagy early during infection, however ASFV supresses 
autophagy at an unknown point later.
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R298L gene encodes for a serine/threonine protein kinase that 
is incorporated into the virus capsid and the phosphoryla-
tion targets of this viral protein are unknown. Transcriptional 
mapping of the ASFV genome has identified at least thirty five 
genes in addition to A179L that are expressed early during 
ASFV replication [71] and therefore could be involved in 
supressing autophagosome formation.
These studies reveal that the inhibition of autophagy by 
ASFV is multi- layered and linked to diverse elements of the 
autophagy pathway (Fig.  6). The involvement of the Akt/
mTORC1 signalling cascade in addition to virally encoded 
modulators could point to a model of phased control. The 
PI3K/Akt pathway may be activated first at the point of virus 
entry to provide a preliminary defence mechanism against 
autophagy but as the viral replication cycle progresses and 
host cell stress responses are activated, an additional level 
of control is implemented by expression of viral factors. In 
this scenario, an attempt to limit the ability of the virus to 
inhibit autophagy by gene deletion would need to address 
both phases of modulation and consequently it may prove 
challenging to overcome this. Nevertheless, this work has 
provided further insight into the complex interaction between 
ASFV and the host cell. As well as implementing an immune 
evasion strategy, ASFV is required to optimise cell function 
for efficient replication as well as prolong cell survival.
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